Liquid biopsy is a safe, non-invasive, highly sensitive and cost-effective method for analyzing circulating cell-free tumor DNA (ctDNA) from the plasma of patients diagnosed with cancer or from individuals at risk of cancer.
Why Liquid Biopsy?
By analyzing ctDNA isolated from the patient's blood, clinically relevant genomic alterations can be detected and matched to targeted therapies and clinical trials.
OnkoGenetiks® Likit Biyopsi gen paneli, kanserin ilerlemesinde en çok rol oynayan yüksek öncelikli genlerin geniş bir spektrumunu kapsar. Belirli genler için hotspot bölgeleri analiz edilir.